FDA to SCO­TUS: Set­ting the mifepri­s­tone reg­u­la­tions clock back to 2016 is 'un­jus­ti­fied'

US So­lic­i­tor Gen­er­al Eliz­a­beth Prel­og­ar has called on the Supreme Court to over­turn an ap­peals court’s de­ci­sion from Au­gust that would roll back some of the reg­u­la­tions around the abor­tion drug mifepri­s­tone.

Writ­ing on be­half of the FDA just be­fore the Thanks­giv­ing hol­i­day, Prel­og­ar ar­gued that the phar­ma in­dus­try “has warned that the court’s le­gal hold­ings would ‘up­end’ a ‘set­tled reg­u­la­to­ry scheme’ and ‘sti­fle phar­ma­ceu­ti­cal in­no­va­tion'” as it would es­sen­tial­ly rep­re­sent a court over­rul­ing the FDA, and bring “out­dat­ed dos­ing and con­di­tions that FDA has now de­ter­mined are un­jus­ti­fied.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER